HYDANTOIN DERIVATIVES AND MALIGNANCIES OF THE HAEMOPOIETIC SYSTEM.BICHEL J.1975; ACTA MED. SCAND.; SUEDE; DA. 1975; VOL. 198; NO 4; PP. 327-328; BIBL. 3 REF.Article

TRAUMA AND HODGKIN'S DISEASEBICHEL J.1979; ACTA MED. SCAND.; SWE; DA. 1979; VOL. 205; NO 4; PP. 347-349; BIBL. 7 REF.Article

Multicentre, open-label study using imiquimod 5% cream in one or two 4-week courses of treatment for multiple actinic keratoses on the headSTOCKFLETH, E; STERRY, W; CAREY-YARD, M et al.British journal of dermatology (1951). 2007, Vol 157, pp 41-46, issn 0007-0963, 6 p., SUP2Article

Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing low-frequency dosing with and without occlusionSTERRY, W; RUZICKA, T; HERRERA, E et al.British journal of dermatology (1951). 2002, Vol 147, Num 6, pp 1227-1236, issn 0007-0963, 10 p.Article

Vehicle-controlled, randomized, double-blind study to assess safety and efficacy of imiquimod 5% cream applied once daily 3 days per week in one or two courses of treatment of actinic keratoses on the headALOMAR, A; BICHEL, J; MCRAE, S et al.British journal of dermatology (1951). 2007, Vol 157, Num 1, pp 133-141, issn 0007-0963, 9 p.Article

A phase II dose-ranging study of topical resiquimodto treat actinic keratosisSZEIMIES, R.-M; BICHEL, J; ORTONNE, J.-P et al.British journal of dermatology (1951). 2008, Vol 159, Num 1, pp 205-210, issn 0007-0963, 6 p.Article

Topical immunomodulation under systemic immunosuppression : results of a multicentre, randomized, placebo-controlled safety and efficacy study of imiquimod 5% cream for the treatment of actinic keratoses in kidney, heart, and liver transplant patientsULRICH, C; BICHEL, J; EUVRARD, S et al.British journal of dermatology (1951). 2007, Vol 157, pp 25-31, issn 0007-0963, 7 p., SUP2Article